Figure - PMC

Skip to main content

An official website of the United States government

Here's how you know

Here's how you know

Official websites use .gov
A .gov website belongs to an official government organization in the United States.

Secure .gov websites use HTTPS
A lock ( ) or https:// means you've safely connected to the .gov website. Share sensitive information only on official, secure websites.

View full-text article in PMC

. 2014 Feb 26;2(3):344–348. doi: 10.3892/br.2014.241

Search in PMC
Search in PubMed
View in NLM Catalog
Add to search

Copyright © 2014, Spandidos Publications

This is an open-access article licensed under a Creative Commons Attribution-NonCommercial 3.0 Unported License. The article may be redistributed, reproduced, and reused for non-commercial purposes, provided the original source is properly cited.

PMC Copyright notice

Survivin mRNA expression in SGC7901/CDDP cells treated with aspirin (3 mmol/l), CDDP (10 μg/ml) and aspirin (3 mmol/l) plus CDDP (10 μg/ml) for 24 h by RT-PCR. (A) Representative RT-PCR analysis of survivin expression. (B) Densitometric analysis of survivin mRNA expression. Data are presented as means ± SD, n=5. ^*P<0.05 vs. untreated SGC7901/CDDP cells (Con). ^**P<0.01 vs. untreated SGC7901/CDDP cells (Con). ^#P<0.05 vs. aspirin (3 mmol/l). ^†P<0.05 vs. CDDP (10 μg/ml). CDDP, cisplatin; Con, control group.

Survivin mRNA expression in SGC7901/CDDP cells treated with aspirin (3 mmol/l), CDDP (10 μg/ml) and aspirin (3 mmol/l) plus CDDP (10 μg/ml) for 24 h by RT-PCR. (A) Representative RT-PCR analysis of survivin expression. (B) Densitometric analysis of survivin mRNA expression. Data are presented as means ± SD, n=5. ^*P<0.05 vs. untreated SGC7901/CDDP cells (Con). ^**P<0.01 vs. untreated SGC7901/CDDP cells (Con). ^#P<0.05 vs. aspirin (3 mmol/l). ^†P<0.05 vs. CDDP (10 μg/ml). CDDP, cisplatin; Con, control group.